1. Home
  2. TCBK vs VIR Comparison

TCBK vs VIR Comparison

Compare TCBK & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBK
  • VIR
  • Stock Information
  • Founded
  • TCBK 1975
  • VIR 2016
  • Country
  • TCBK United States
  • VIR United States
  • Employees
  • TCBK N/A
  • VIR N/A
  • Industry
  • TCBK Major Banks
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCBK Finance
  • VIR Health Care
  • Exchange
  • TCBK Nasdaq
  • VIR Nasdaq
  • Market Cap
  • TCBK 1.5B
  • VIR 1.4B
  • IPO Year
  • TCBK N/A
  • VIR 2019
  • Fundamental
  • Price
  • TCBK $41.75
  • VIR $7.96
  • Analyst Decision
  • TCBK Hold
  • VIR Buy
  • Analyst Count
  • TCBK 5
  • VIR 6
  • Target Price
  • TCBK $50.75
  • VIR $34.83
  • AVG Volume (30 Days)
  • TCBK 102.2K
  • VIR 1.2M
  • Earning Date
  • TCBK 04-24-2025
  • VIR 05-01-2025
  • Dividend Yield
  • TCBK 3.16%
  • VIR N/A
  • EPS Growth
  • TCBK N/A
  • VIR N/A
  • EPS
  • TCBK 3.46
  • VIR N/A
  • Revenue
  • TCBK $389,190,000.00
  • VIR $74,205,000.00
  • Revenue This Year
  • TCBK $8.08
  • VIR N/A
  • Revenue Next Year
  • TCBK $5.63
  • VIR $24.90
  • P/E Ratio
  • TCBK $12.07
  • VIR N/A
  • Revenue Growth
  • TCBK N/A
  • VIR N/A
  • 52 Week Low
  • TCBK $31.73
  • VIR $6.56
  • 52 Week High
  • TCBK $51.06
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • TCBK 33.39
  • VIR 36.18
  • Support Level
  • TCBK $40.92
  • VIR $7.61
  • Resistance Level
  • TCBK $44.16
  • VIR $8.51
  • Average True Range (ATR)
  • TCBK 0.93
  • VIR 0.56
  • MACD
  • TCBK -0.27
  • VIR -0.15
  • Stochastic Oscillator
  • TCBK 20.00
  • VIR 14.77

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of Treasury Management Services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: